课题基金 / 基金详情

Investigation of curative effect and the neuroplasticity with the start time in the gene therapy of the cerebellar ataxic mouse

Investigation of curative effect and the neuroplasticity with the start time in the gene therapy of the cerebellar ataxic mouse
小脑共济失调小鼠基因治疗的疗效及神经可塑性与起始时间的探讨
批准号:
22700374
负责人:
IIZUKA Akira
金额:
$2.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2011

项目摘要

项目成果

IIZUKA Akira的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Lentiviral vectors expressing RORα were injected into the cerebellar cortex of P6, P13 or P20 staggerer mice, and the effects were studied 3 weeks after the injection. Staggerer mice lentivirally treated at P6 showed marked dendritic differentiation of PCs and removal CF synapses from PCs, whereas those lentivirally treated at P13 displayed only a partial rescue of dendritic differentiation and failure of removal of CF synapses from PCs. No rescue was observed in staggerer mice lentivirally treated at P20. Together with evidence that protein expression in the brain starts about 5 days after lentiviral vector injection, these results suggest that staggerer mutant cerebellum maintains potential to respond to RORα at 2nd postnatal week, but loses almost completely at 4th postnatal week.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Long-term oral administration of the NMDA receptor antagonist memantine extends life span in spinocerebellar ataxia type 1 knock-in mice.
  • 批准号:
    25830046
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $2.66万
  • 财政年份:
    2013
  • 负责人:
    IIZUKA Akira
  • 依托单位:
海外基金